5 employees
EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.
2012
$11M
from 2 investors over 2 rounds
EnBiotix, Inc. raised $11M on December 29, 2021
Investors: Vectura
EnBiotix, Inc. raised undisclosed on May 12, 2016
Investors: Apeiron Partners LLC